AMXUDE
Live / Allowed — Publication / registration review complete (as of 12 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Aug 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 50069752
- Mark type
- Word mark
- Filed
- 25 Aug 2026
- Published for opposition
- 03 Nov 2026
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies
Owner
- Teva Pharmaceutical Industries Ltd., Tel Aviv, IL
Prosecution history
- 30 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Sept 2026 — ASSIGNED TO EXAMINER
- 25 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 25 Aug 2026 — NEW APPLICATION ENTERED